306
Views
5
CrossRef citations to date
0
Altmetric
Review Articles

Vagus nerve stimulation for treatment-resistant depression: is this therapy distinct from other antidepressant treatments?

&
Pages 349-356 | Received 26 Sep 2019, Accepted 01 Jun 2020, Published online: 17 Jul 2020

References

  • Aalbers M, Vles J, Klinkenberg S, Hoogland G, Majoie M, Rijkers K. 2011. Animal models for vagus nerve stimulation in epilepsy. Exp Neurol. 230(2):167–175.
  • Aaronson ST, Carpenter LL, Conway CR, Reimherr FW, Lisanby SH, Schwartz TL, Moreno FA, Dunner DL, Lesem MD, Thompson PM, et al. 2013. Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimul. 6(4):631–640.
  • Aaronson ST, Sears P, Ruvuna F, Bunker M, Conway CR, Dougherty DD, Reimherr FW, Schwartz TL, Zajecka JM. 2017. A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: comparison of response, remission, and suicidality. Am J Psychiatry. 174(7):640–648.
  • Bajbouj M, Merkl A, Schlaepfer TE, Frick C, Zobel A, Maier W, O'Keane V, Corcoran C, Adolfsson R, Trimble M, et al. 2010. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol. 30:273–281.
  • Ben-Menachem E, Revesz D, Simon BJ, Silberstein S. 2015. Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability. Eur J Neurol. 22(9):1260–1268.
  • Berry SM, Broglio K, Bunker M, Jayewardene A, Olin B, Rush AJ. 2013. A patient-level metaanalysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression. Med Devices. 6:17–35.
  • Bottomley JM, Lereun C, Diamantopoulos A, Mitchell S, Gaynes BN. 2020. Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: a systematic review and meta-analysis. Comprehensive Psychiatry. 98:152156.
  • Chae J-H, Nahas Z, Lomarev M, Denslow S, Lorberbaum JP, Bohning DE, George MS. 2003. A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res. 37(6):443–455.
  • Christmas D, Steele JD, Tolomeo S, Eljamel MS, Matthews K. 2013. Vagus nerve stimulation for chronic major depressive disorder: 12-month outcomes in highly treatment-refractory patients. J Affect Disord. 150(3):1221–1225.
  • Cimpianu C-L, Strube W, Falkai P, Palm U, Hasan A. 2017. Vagus nerve stimulation in psychiatry: a systematic review of the available evidence. J Neural Transm (Vienna). 124(1):145–158.
  • Conway CR, Chibnall JT, Gebara MA, Price JL, Snyder AZ, Mintun MA, Craig ADB, Cornell ME, Perantie DC, Giuffra LA, et al. 2013. Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression. Brain Stimul. 6(5):788–797.
  • Conway CR, Kumar A, Xiong W, Bunker M, Aaronson ST, Rush AJ. 2018. Chronic vagus nerve stimulation significantly improves quality of life in treatment-resistant major depression. J Clin Psychiatry. 79(5):18m12178.
  • Conway CR, Xiong W. 2018. The mechanism of action of vagus nerve stimulation in treatmentresistant depression: current conceptualizations. Psychiatr Clin North Am. 41(3):395–407.
  • Cristancho P, Cristancho MA, Baltuch GH, Thase ME, O’ Reardon JP. 2011. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year. J Clin Psychiatry. 72(10):1376–1382.
  • Cyberonics. 2015. VNS therapy system physician’s manual. Houston (TX): Cyberonics Inc.
  • Daban C, Martinez-Aran A, Cruz N, Vieta E. 2008. Safety and efficacy of vagus nerve stimulation in treatment-resistant depression: a systematic review. J Affect Disord. 110(1–2):1–15.
  • Desbeaumes JV, Richer F, Miron JP, Fournier-Gosselin MP, Lespérance P. 2018. Long-term sustained cognitive benefits of vagus nerve stimulation in refractory depression. J ECT. 34:283–290.
  • Feldman RL, Dunner DL, Muller JS, Stone DA. 2013. Medicare patient experience with vagus nerve stimulation for treatment-resistant depression. J Med Econ. 16(1):62–74.
  • Follesa P, Biggio F, Gorini G, Caria S, Talani G, Dazzi L, Puligheddu M, Marrosu F, Biggio G. 2007. Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Res. 1179:28–34.
  • Furmaga H, Carreno FR, Frazer A. 2012. Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain. PLoS One. 7(5):e34844.
  • Grimonprez A, Raedt R, Baeken C, Boon P, Vonck K. 2015. The antidepressant mechanism of action of vagus nerve stimulation: evidence from preclinical studies. Neurosci Biobehav Rev. 56:26–34.
  • Groves DA, Brown VJ. 2005. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev. 29(3):493–500.
  • Hulsey DR, Shedd CM, Sarker SF, Kilgard MP, Hays SA. 2019. Norepinephrine and serotonin are required for vagus nerve stimulation directed cortical plasticity. Exp Neurol. 320:112975.
  • Kumar A, Bunker MT, Aaronson ST, Conway CR, Rothschild AJ, Mordenti G, Rush AJ. 2019. Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression. Neuropsychiatr Dis Treat. 15:457–468.
  • Liu W, Ge T, Leng Y, Pan Z, Fan J, Yang W, Cui R. 2017. The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast. 2017:11.
  • Lv H, Zhao Y-H, Chen G-J, Wang D-Y, Chen H. 2019. Vagus nerve stimulation for depression: a systematic review. Front Psychol. 10:64.
  • Martin JLR, Martín-Sánchez E. 2012. Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: variable results based on study designs. Eur Psychiatr. 27(3):147–155.
  • McGirr A, Berlim MT. 2018. Clinical usefulness of therapeutic neuromodulation for major depression: a systematic meta-review of recent meta-analyses. Psychiatr Clin North Am. 41(3):485–503.
  • Mehta V, Kramer D, Russin J, Liu C, Amar A. 2018. Chapter 82: vagal nerve simulation. In: Elliot Krames, Ali Rezai, and Hunter Peckham, editors. Neuromodulation. Comprehensive Textbook of Principles, Technologies, and Therapies. Book.2nd ed. p. 999–1009.
  • Milev RV, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J, Modirrousta M, Patry S, Vila-Rodriguez F, Lam RW, et al. 2016. Clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation treatments. Can J Psychiatry. 61(9):561–575.
  • Müller HH, Kornhuber J, Maler JM, Sperling W. 2013. The effects of stimulation parameters on clinical outcomes in patients with vagus nerve stimulation implants with major depression. J ECT. 29:e40–e42.
  • Müller HH, Lücke C, Moeller S, Philipsen A, Sperling W. 2017. Efficacy and long-term tuning parameters of vagus nerve stimulation in long-term treated depressive patients. J Clin Neurosci. 44:340–341.
  • Müller HH, Moeller S, Lam A, Lücke C, Braun N, Philipsen A. 2018. Vagus nerve stimulation (VNS) and other augmentation strategies for therapy-resistant depression (TRD): review of the evidence and clinical advice for use. Front Neurosci. 12:239.
  • Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, Martinez JM, George MS. 2005. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry. 66(9):1097–1104.
  • Nahas Z, Teneback C, Chae J-H, Mu Q, Molnar C, Kozel FA, Walker J, Anderson B, Koola J, Kose S, et al. 2007. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology. 32(8):1649–1660.
  • Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, George MS, Charney DS, Brannan SK. 2006. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology. 31(7):1345–1355.
  • Nierenberg AA, Alpert JE, Gardner-Schuster EE, Seay S, Mischoulon D. 2008. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol Psychiatry. 64(6):455–460.
  • Olin B, Jayewardene AK, Bunker M, Moreno F. 2012. Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention. PLoS One. 7(10):e48002.
  • Penry JK, Dean JC. 1990. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results. Epilepsia. 31(s2):S40–S43.
  • Perini GI, Toffanin T, Pigato G, Ferri G, Follador H, Zonta F, Pastorelli C, Piazzon G, Denaro L, Rolma G, et al. 2017. Hippocampal gray volumes increase in treatment-resistant depression responding to vagus nerve stimulation. J ECT. 33:160166.
  • Revesz D, Tjernstrom M, Ben-Menachem E, Thorlin T. 2008. Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation. Exp Neurol. 214(2):259–265.
  • Ruffoli R, Giorgi FS, Pizzanelli C, Murri L, Paparelli A, Fornai F. 2011. The chemical neuroanatomy of vagus nerve stimulation. J Chem Neuroanat. 42(4):288–296.
  • Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C, Nahas Z, Haines S, Simpson RK, Goodman R. 2000. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry. 47(4):276–286.
  • Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, et al. 2005a. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 58(5):347–354.
  • Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, et al. 2005b. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry. 58(5):355–363.
  • Rush AJ, Siefert SE. 2009. Clinical issues in considering vagus nerve stimulation for treatment-resistant depression. Exp Neurol. 219(1):36–43.
  • Sackeim HA, Keilp JG, Rush AJ, George MS, Marangell LB, Dormer JS, Burt T, Lisanby SH, Husain M, Cullum CM, et al. 2001. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol Behav Neurol. 14(1):53–62.
  • Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M, O'Keane V, Corcoran C, Adolfsson R, Trimble M, et al. 2008. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med. 38(5):651–661.
  • Trottier-Duclos F, Desbeaumes Jodoin V, Fournier-Gosselin M-P, Richer F, Desjardins N, Tieu S, Lespérance P. 2018. A 6-year follow-up study of vagus nerve stimulation effect on quality of life in treatmentresistant depression: a pilot study. J ECT. 34(4):E58–E60.
  • Vonck KJ, Larsen LE. 2018. Chapter 18. Vagus nerve stimulation: mechanism of action. In: Krames E, Peckham PH, Rezai AR, editors. Neuromodulation: comprehensive textbook of principles, technologies, and therapies. Vol. 1. London, United Kingdom: Elsevier. p. 211–220.
  • Yuan H, Silberstein S. 2016. Vagus nerve and vagus nerve stimulation, a comprehensive review: part II. Headache. 56(2):259–266.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.